Mercury Bio Inc. , an immunology-driven biotechnology company developing intracellular therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's, today announced MB-TIP(TM) (Mercury ...
Cardiotoxicity of immune checkpoint inhibitors: A retrospective cohort study of 93,362 patients. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a ...
Researchers create nanomachines using metal and polyphenols, which enhance targeted intracellular delivery of antibodies for cancer therapy. (Nanowerk News) In a significant step towards improving ...
A new article in the peer-reviewed journal Nucleic Acid Therapeutics describes the characterization of antibodies targeting antisense oligonucleotide (ASO) phosphorothioate and 2'-methoxyehtyl ...
Orum Therapeutics Presents Preclinical Data at ASH 2025 Demonstrating Potent and Selective Antitumor Activity of ORM-1153, a CD123-Targeting Degrader Antibody Conjugate for Acute Myeloid Leukemia Orum ...
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes (TILs) may be effective for patients with metastatic colorectal cancer (CRC) refractory to ...
Researchers in Japan have created a unique nanocarrier technology that delivers therapeutic antibodies directly to target antigens inside cancer cells, marking an important breakthrough toward better ...
Delivering cutting-edge peer-reviewed research on using nucleic acids and related compounds to alter gene expression for therapeutic purposes. A new article in the peer-reviewed journal Nucleic Acid ...
Mercury Bio Inc. , an immunology-driven biotechnology company developing intracellular therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's, today announced MB-TIP™ (Mercury ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback